The HLT Meridian TAVR Valve System is designed to overcome some of the challenges of current FDA-cleared TAVR devices.
Siemens Healthineers has announced that it has received CE Mark for the AcuNav Volume ICE (intracardiac echocardiography) catheter, an imaging guide that provides real-time, wide-angle visualization of heart anatomy during structural heart and electrophysiology procedures.
People who have a pacemaker or an implantable cardioverter defibrillator should be aware that the magnets used in the wireless charging technology for the series 12 models of the Apple iPhone can affect how the cardiac devices work if the phones are stored or used in close proximity to the implanted cardiac device, according to […]
Femoral pseudoaneurysms usually develop when the femoral artery puncture site is too low and the needle insertion is in the profunda femoris artery. We describe here a pseudoaneurysm that developed in the common femoral artery, due to inadequate manual compression and immobilization of the limb. This was dealt with by intra-aneurysm instillation of coils and […]
The joint opinion outlines comprehensive tobacco prevention strategies that are necessary to fully implement the MPOWER framework.
iRhythm Technologies has announced two US Food and Drug Administration (FDA) 510K clearances—one for a new and improved design of its flagship monitor and a second for updated artificial intelligence (AI) capabilities.
Treating chronic total occlusions (CTOs), complex bifurcations, heavily calcified lesions, and left main coronary artery disease with large-bore catheters via the radial artery is associated with significantly less access-site bleeding and fewer vascular complications when compared with femoral access, according to the results of the COLOR study.
A rigorous meta-analysis of randomized clinical trials (RCTs) that compared the effects of medical therapies alone with medical therapies plus revascularization in patients with stable ischemic heart disease (SIHD) was presented at EuroPCR on May 18, 2021.
This “hyperinvasive” approach performed better than expected outcomes also seen in patients who received standard advanced cardiac life support.
Researchers suggested that renal denervation may be an alternative to prescribing more antihypertensive therapies to patients with resistant hypertension, according to research presented at the American College of Cardiology Scientific Session and simultaneously published in The Lancet.
Stay Up-To-Date on jobs and industry news.
Sign up for the CathLab.com newsletter today!